Teladoc (NYSE:TDOC) had its price objective boosted by Canaccord Genuity from $43.00 to $45.00 in a research report report published on Wednesday morning. Canaccord Genuity currently has a buy rating on the health services provider’s stock.
Several other analysts also recently weighed in on TDOC. Cantor Fitzgerald restated a hold rating and issued a $35.00 price objective (up from $31.00) on shares of Teladoc in a report on Tuesday. Chardan Capital restated a buy rating and issued a $47.00 price objective (down from $48.00) on shares of Teladoc in a report on Wednesday. ValuEngine upgraded Teladoc from a sell rating to a hold rating in a report on Friday, February 2nd. KeyCorp restated a buy rating and issued a $39.00 price objective on shares of Teladoc in a report on Monday, December 4th. Finally, CIBC reiterated an outperform rating and issued a $45.00 target price (up previously from $40.00) on shares of Teladoc in a research note on Tuesday, November 21st. One research analyst has rated the stock with a sell rating, five have issued a hold rating and twelve have given a buy rating to the company’s stock. The company presently has an average rating of Buy and an average price target of $40.29.
Shares of Teladoc (NYSE:TDOC) opened at $40.10 on Wednesday. The company has a debt-to-equity ratio of 0.83, a quick ratio of 5.08 and a current ratio of 5.08. The firm has a market capitalization of $2,302.40, a price-to-earnings ratio of -21.22 and a beta of 0.49. Teladoc has a 52-week low of $19.60 and a 52-week high of $41.00.
A number of large investors have recently made changes to their positions in the business. American International Group Inc. lifted its holdings in Teladoc by 8.1% in the third quarter. American International Group Inc. now owns 36,079 shares of the health services provider’s stock valued at $1,196,000 after acquiring an additional 2,697 shares during the period. Ameritas Investment Partners Inc. lifted its holdings in Teladoc by 134.2% in the second quarter. Ameritas Investment Partners Inc. now owns 4,724 shares of the health services provider’s stock valued at $164,000 after acquiring an additional 2,707 shares during the period. Emerald Advisers Inc. PA lifted its holdings in Teladoc by 0.5% in the fourth quarter. Emerald Advisers Inc. PA now owns 566,096 shares of the health services provider’s stock valued at $19,728,000 after acquiring an additional 2,784 shares during the period. SG Americas Securities LLC acquired a new position in Teladoc in the fourth quarter valued at approximately $101,000. Finally, Brown Advisory Inc. lifted its holdings in Teladoc by 38.3% in the third quarter. Brown Advisory Inc. now owns 10,521 shares of the health services provider’s stock valued at $348,000 after acquiring an additional 2,915 shares during the period.
COPYRIGHT VIOLATION NOTICE: “Teladoc (TDOC) PT Raised to $45.00” was published by Ticker Report and is the sole property of of Ticker Report. If you are accessing this piece of content on another publication, it was stolen and reposted in violation of United States and international trademark & copyright laws. The correct version of this piece of content can be read at https://www.tickerreport.com/banking-finance/3230928/teladoc-tdoc-pt-raised-to-45-00.html.
Teladoc, Inc is a telehealth company. The Company offers telehealth platform, delivering on-demand healthcare anytime, anywhere, through mobile devices, the Internet, video and phone. The Company’s solution connects its Members, with its over 3,000 board certified physicians and behavioral health professionals treating a range of conditions and cases from acute diagnoses, such as upper respiratory infection, urinary tract infection and sinusitis to dermatological conditions, anxiety and smoking cessation.
Receive News & Ratings for Teladoc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc and related companies with MarketBeat.com's FREE daily email newsletter.